The medical device world has sought to leverage a minimally surgical procedure and ablate the the renal artery to lower blood pressure for years but no winner is yet to emerge with a successful therapy.

Source: https://medcitynews.com/2023/01/a-vcs-take-on-the-1-3-billion-acquisition-of-cincor-pharma-by-astrazeneca/